Adverum Biotechnologies, Inc. (ADVM) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Cash from Operations | -28.11M | -38.77M | -42.77M | -28.25M | -21.12M | -19.84M | -23.25M | -21.4M | -23.91M | -23.25M | -22.41M | -18.48M | -31.81M | -28.88M | -28.93M | -25.82M | -25.8M | -33.91M | -22.3M | -22.22M |
| Operating CF Margin % | - | - | - | - | -2112.4% | - | - | - | - | - | -622.56% | - | - | - | - | - | - | - | -297.4% | - |
| Operating CF Growth % | -33.1% | -95.36% | -84% | -31.98% | 11.66% | 14.65% | -3.72% | -15.85% | 24.82% | 19.5% | 22.53% | 28.43% | -23.31% | 14.85% | -29.7% | -16.16% | 2.82% | -100.6% | -63.81% | -49.81% |
| Net Income | -47.65M | -49.19M | -47.02M | -40.93M | -12.75M | -18.48M | -24.79M | -23.71M | -32.88M | -31.51M | -29.06M | -32.74M | -40.13M | -43.76M | -37.91M | -34.41M | -38.36M | -44.33M | -28.44M | -37.63M |
| Depreciation & Amortization | 465K | 535K | 683K | 810K | 890K | 956K | 997K | 1.01M | 1.51M | 1.53M | 1.59M | 1.71M | 1.79M | 1.6M | 1.43M | 1.32M | 962K | 1.2M | 1.17M | 1.08M |
| Stock-Based Compensation | 2.35M | 2.42M | 2.78M | 0 | 2.96M | 3.94M | 4.17M | 4.15M | 4.39M | 4.47M | 4.56M | 0 | 4.5M | 0 | 0 | 4.41M | 5.33M | 8.23M | 7.22M | 6.18M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.47M | -75K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.95M | 543K | 855K | 1.64M |
| Other Non-Cash Items | 76K | -24K | 572K | 2.94M | -4.72M | -8.25M | -1.12M | 7.3M | 5.58M | 4.47M | 486K | 4.89M | -1.99M | 7.12M | 5.5M | 595K | -51K | -39K | -42K | 50K |
| Working Capital Changes | 16.65M | 7.49M | 215K | 8.93M | -7.5M | 1.98M | -2.5M | -3.68M | -2.43M | -2.21M | 3K | 7.66M | 4.02M | 6.16M | 2.05M | 2.27M | 4.38M | 485K | -3.07M | 6.47M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 7.74M | 2.88M | 218K | -449K | 298K | 236K | -347K | -307K | 882K | -1.57M | 631K | 1.39M | -3.76M | 1.78M | 1.44M | -1.02M | -193K | 369K | -763K | 141K |
| Cash from Investing | 1.86M | 31.9M | 31.28M | -4.19M | -13.35M | -2.33M | -22.03M | -9.88M | 18.2M | 67.02M | 21.53M | 2.23M | 24.37M | 30.73M | 84.38M | 23.88M | 10.47M | 37.78M | 6.58M | 11.58M |
| Capital Expenditures | -142K | -120K | -220K | -61K | -221K | -16K | -90K | -192K | -495K | -36K | -85K | -185K | -824K | -6.43M | -4.37M | -4.35M | -5.72M | -3.65M | -1.4M | -1.43M |
| CapEx % of Revenue | - | - | - | - | 22.1% | - | - | - | - | - | 2.36% | - | - | - | - | - | - | - | 18.72% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 9.9M | 120K | 0 | 239K | 0 | -116K | 119.88M | 242K | -105K | 8K | 0 | 242K | 4.3M | 362K | 3K | 375K | 0 | 517K | 1.5M | 376K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -240K | -32K |
| Equity Issued (Net) | 1000K | 120K | 0 | 239K | 0 | -380K | 1000K | 242K | 1K | 0 | 0 | 242K | 0 | 362K | 3K | 0 | 0 | -9K | 1000K | -245K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 264K | 139K | 0 | -106K | 8K | 0 | 0 | 4.3M | 0 | 0 | 375K | 0 | 526K | 51K | 653K |
| Net Change in Cash | -16.36M | -6.74M | -11.49M | -32.2M | -34.47M | -22.29M | 74.61M | -30.37M | -5.82M | 43.78M | -879K | -16M | -7.44M | 2.22M | 55.46M | -1.56M | -15.33M | 4.38M | -14.22M | -10.27M |
| Free Cash Flow | -28.26M | -38.89M | -42.99M | -28.31M | -21.34M | -19.86M | -23.34M | -21.6M | -24.41M | -23.29M | -22.5M | -18.66M | -32.63M | -35.31M | -33.3M | -30.17M | -31.52M | -37.56M | -23.71M | -23.66M |
| FCF Margin % | - | - | - | - | -2134.5% | - | - | - | - | - | -624.92% | - | - | - | - | - | - | - | -316.12% | - |
| FCF Growth % | -32.38% | -95.81% | -84.23% | -31.09% | 12.55% | 14.71% | -3.72% | -15.73% | 25.2% | 34.06% | 32.45% | 38.14% | -3.54% | 5.99% | -40.47% | -27.52% | -6.37% | -87.58% | -33% | -1.93% |
| FCF per Share | -1.20 | -1.85 | -2.05 | -1.35 | -1.02 | -0.95 | -1.42 | -0.37 | -0.42 | -0.40 | -0.39 | -0.32 | -0.33 | -0.36 | -0.34 | -0.31 | -0.32 | -0.38 | -0.24 | -0.24 |
| FCF Conversion (FCF/Net Income) | 0.59x | 0.79x | 0.91x | 0.47x | 0.78x | 0.65x | 0.86x | 0.90x | 0.73x | 0.74x | 0.77x | 0.56x | 0.79x | 0.66x | 0.76x | 0.75x | 0.67x | 0.77x | 0.78x | 0.59x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |